These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 27958766)

  • 21. Treatment of severe hypertriglyceridemia lowers plasma viscosity.
    Stein JH; Rosenson RS
    Atherosclerosis; 1998 Apr; 137(2):401-5. PubMed ID: 9622283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypertriglyceridemia as a possible independent risk factor for stroke.
    Lisak M; Demarin V; Trkanjec Z; Basić-Kes V
    Acta Clin Croat; 2013 Dec; 52(4):458-63. PubMed ID: 24696996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Post-prandial effects of gemfibrozil vs simvastatin in hypercholesterolemic subjects with borderline hypertriglyceridemia.
    Vigna GB; Donega P; Passaro A; Zanca R; Cattin L; Fonda M; Pauciullo P; Marotta G; Fellin R; Gasparrini S; Piliego T
    Nutr Metab Cardiovasc Dis; 1999 Oct; 9(5):234-43. PubMed ID: 10656170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effects of Xuezhikang on serum lipid profile, thromboxane A2 and prostacyclin in patients with hyperlipidemia].
    Jian J; Hao X; Deng C; Zhou H; Lin J
    Zhonghua Nei Ke Za Zhi; 1999 Aug; 38(8):517-9. PubMed ID: 11798687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gemfibrozil lowers plasma lipids and increases polyunsaturated fatty acid content and oxidative susceptibility of lipoproteins in hypertriglyceridemia.
    Smith WG; Wang J; Dang AQ; Reeves C; Bibbs D; Faas FH
    Clin Chim Acta; 2002 Aug; 322(1-2):77-84. PubMed ID: 12104084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gemfibrozil predictably lowers triglycerides but does not significantly change plasminogen activator inhibitor activity in hypertriglyceridemic patients with a history of thrombosis.
    Haire WD
    Thromb Res; 1991 Nov; 64(4):493-501. PubMed ID: 1788834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum lipoprotein-associated phospholipase A₂ and C-reactive protein levels in association with periodontal disease and hyperlipidemia.
    Fentoğlu O; Köroğlu BK; Kara Y; Doğan B; Yılmaz G; Sütçü R; Ay ZY; Tonguç MÖ; Orhan H; Tamer MN; Kırzıoğlu FY
    J Periodontol; 2011 Mar; 82(3):350-9. PubMed ID: 20809860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An observational study of severe hypertriglyceridemia, hypertriglyceridemic acute pancreatitis, and failure of triglyceride-lowering therapy when estrogens are given to women with and without familial hypertriglyceridemia.
    Goldenberg NM; Wang P; Glueck CJ
    Clin Chim Acta; 2003 Jun; 332(1-2):11-9. PubMed ID: 12763274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin therapy for a non-diabetic patient with severe hypertriglyceridemia.
    Jabbar MA; Zuhri-Yafi MI; Larrea J
    J Am Coll Nutr; 1998 Oct; 17(5):458-61. PubMed ID: 9791843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postprandial lipoprotein metabolism in obese patients with moderate hypertriglyceridaemia: effects of gemfibrozil.
    Ditschuneit HH; Flechtner-Mors M; Hagel E; Ditschuneit H
    J Int Med Res; 1992 Jun; 20(3):197-210. PubMed ID: 1397665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
    Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reducing hypertriglyceridemia in elderly patients with cerebrovascular disease stabilizes or improves cognition and cerebral perfusion.
    Rogers RL; Meyer JS; McClintic K; Mortel KF
    Angiology; 1989 Apr; 40(4 Pt 1):260-9. PubMed ID: 2705633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of simvastatin and hyperlipidemia with periodontal status and bone metabolism markers.
    Magán-Fernández A; Papay-Ramírez L; Tomás J; Marfil-Álvarez R; Rizzo M; Bravo M; Mesa F
    J Periodontol; 2014 Oct; 85(10):1408-15. PubMed ID: 24555750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gemfibrozil effectively lowers protease inhibitor-associated hypertriglyceridemia in HIV-1-positive patients.
    Hewitt RG; Shelton MJ; Esch LD
    AIDS; 1999 May; 13(7):868-9. PubMed ID: 10357393
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of gemfibrozil (Lopid) on hyperlipidemia in acitretin-treated patients. Results of a double-blind cross-over study.
    Vahlquist C; Olsson AG; Lindholm A; Vahlquist A
    Acta Derm Venereol; 1995 Sep; 75(5):377-80. PubMed ID: 8615057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of gemfibrozil on adipose tissue and muscle lipoprotein lipase.
    Simsolo RB; Ong JM; Kern PA
    Metabolism; 1993 Nov; 42(11):1486-91. PubMed ID: 8231846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of lovastatin and gemfibrozil in subjects with high ratios of total cholesterol to high-density lipoprotein cholesterol.
    Hung YJ; Pei D; Wu DA; Kuo SW; Fuh MM; Jeng C
    J Formos Med Assoc; 1999 Feb; 98(2):104-10. PubMed ID: 10083765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of gemfibrozil therapy on glucose tolerance, insulin sensitivity and plasma plasminogen activator inhibitor activity in hypertriglyceridaemia.
    Asplund-Carlson A
    J Cardiovasc Risk; 1996 Aug; 3(4):385-90. PubMed ID: 8946270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gemfibrozil increases paraoxonase activity in type 2 diabetic patients. A new hypothesis of the beneficial action of fibrates?
    Balogh Z; Seres I; Harangi M; Kovács P; Kakuk G; Paragh G
    Diabetes Metab; 2001 Nov; 27(5 Pt 1):604-10. PubMed ID: 11694861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of fibrates in the management of hypertriglyceridemia.
    Rader DJ; Haffner SM
    Am J Cardiol; 1999 May; 83(9B):30F-35F. PubMed ID: 10357573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.